Results 131 to 140 of about 636 (203)

Th2 predominance and decreased NK cells in patients with hereditary angioedema. [PDF]

Front Immunol
Sundler Björkman L, Elmér E, Egesten A, Skattum L.   +3 more
europepmc   +1 more source

Real-world treatment patterns and clinical burden of patients with hereditary angioedema treated with long-term prophylaxis. [PDF]

Orphanet J Rare Dis
Lumry W, Zbrozek A, Thompson-Leduc P, Vera-Llonch M, Gauthier-Loiselle M, Vanden Eynde C, Tardif-Samson A, Guérin A, Radojicic C.   +8 more
europepmc   +1 more source

El Angioedema hereditario en la Provincia de Villa Clara desde 1999 a la actualidad, avances y desafíos

Acta Médica del Centro
Lay Salazar Torres
doaj  

Probiotic supplementation to mitigate berotralstat gastrointestinal side effects: a multicenter case series from the ITACA network. [PDF]

Front Immunol
Gidaro A, Guarino MD, Arcoleo F, Bignardi D, D'Antonio C, Brussino L, Accardo P, Nicola S, Pucci S, Cognigni M, Popescu Janu V, Cogliati C, Bizzi E, Cancian M.   +13 more
europepmc   +1 more source

Hereditary Angioedema Prophylaxis Therapy: Berotralstat and Lanadelumab Safety Profile. [PDF]

Medicina (Kaunas)
Donadoni M, La Cava L, Bizzi E, Popescu Janu V, Meschia A, Cirigliano F, Cogliati C, Gidaro A.   +7 more
europepmc   +1 more source

Transmission of F12-related hereditary angioedema through a sperm donor. [PDF]

Front Immunol
Marquès L, Batlle-Masó L, Alcoceba E, Lara S, Aguiló-Cucurull A, Gil-Serrano J, Guilarte M, Colobran R.   +7 more
europepmc   +1 more source

Epidemiological and clinical characteristics of hereditary angioedema in the Baltic states. [PDF]

Front Immunol
Kurjane N, Kanepa A, Purina S, Lapina L, Ress K, Savisaar M, Gasiuniene E, Bajoriuniene I, Linauskiene K, Chomiciene A, Gradauskiene B, Malinauskiene L.   +11 more
europepmc   +1 more source

Management of pregnancy, delivery and breast-feeding in hereditary angioedema: an analysis of 15 pregnancies with conventional treatment approaches and a case of Lanadelumab use. [PDF]

Orphanet J Rare Dis
Casanova M, Brüggen MC, Wuillemin WA, Weber-Chrysochoou C.   +3 more
europepmc   +1 more source

Selection of initiatives to improve the management of patients with hereditary angioedema by the hospital pharmacy using the nominal group technique. [PDF]

Eur J Hosp Pharm
Montoro Ronsano JB, Martínez Sesmero JM, Cortés I, Lleonart R.   +3 more
europepmc   +1 more source

Acquired angioedema due to C1 inhibitor deficiency: real-world clinical characteristics and treatment outcomes. [PDF]

Front Immunol
Toprak İD, Erdem S, Korkmaz P, Unal D, Yegit OO, Hormet Igde M, Çelik Kamacı Ş, Çetin O, Öztop N, Demir S, Tüzer C, Mastanzade M, Elverdi T, Sezgin ME, Kalayoğlu Beşışık S, Gelincik A.   +15 more
europepmc   +1 more source